US Patent Issued to THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Services on Sept. 1 for "Gene therapy for treatment of CRX -autosomal dominant retinopathies" (Maryland Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,721,908, issued on Sept. 1, was assigned to THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Services (Bethesda, Md.).

"Gene therapy for treatment of CRX -autosomal dominant retinopathies" was invented by Anand Swaroop (Bethesda, Md.), Zhijian Wu (Bethesda, Md.), Suja D. Hiriyanna (Bethesda, Md.) and Kamil Kruczek (Bethesda, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods are disclosed for treating a cone rod homeobox transcription factor (CRX) autosomal dominant retinopathy in a subject. These methods include administering to the subject an effective amount of a nucleic acid molecule comprising a ...